Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10

Biochemical Journal - Tập 424 Số 1 - Trang 79-88 - 2009
Cristina I. Caescu1, Grace R. Jeschke1, Benjamin E. Turk1
1Department of Pharmacology, Yale University School of Medicine, P.O. Box 208066, 333 Cedar Street, New Haven, CT 06520, U.S.A.

Tóm tắt

The metalloproteinases TACE [tumour necrosis factor α-converting enzyme; also known as ADAM17 (a disintegrin and metalloproteinase 17)] and ADAM10 are the primary enzymes responsible for catalysing release of membrane-anchored proteins from the cell surface in metazoan organisms. Although the repertoire of protein substrates for these two proteases is partially overlapping, each one appears to target a subset of unique proteins in vivo. The mechanisms by which the two proteases achieve specificity for particular substrates are not completely understood. We have used peptide libraries to define the cleavage site selectivity of TACE and ADAM10. The two proteases have distinct primary sequence requirements at multiple positions surrounding the cleavage site in their substrates, which allowed us to generate peptide substrates that are highly specific for each of these proteases. The major difference between the two protease specificities maps to the P1′ position (immediately downstream of the cleavage site) of the substrate. At this position, TACE is selective for smaller aliphatic residues, whereas ADAM10 can accommodate aromatic amino acids. Using mutagenesis we identified three residues in the S1′ pockets of these enzymes that dramatically influence specificity for both peptide and protein substrates. Our results suggest that substrate selectivity of TACE and ADAM10 can be at least partly rationalized by specific features of their active sites.

Từ khóa


Tài liệu tham khảo

Becherer, 2003, Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs), Curr. Top. Dev. Biol., 54, 101, 10.1016/S0070-2153(03)54006-6

Black, 1998, ADAMs: focus on the protease domain, Curr. Opin. Cell Biol., 10, 654, 10.1016/S0955-0674(98)80042-2

Black, 1997, A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells, Nature, 385, 729, 10.1038/385729a0

Moss, 1997, Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α, Nature, 385, 733, 10.1038/385733a0

Peschon, 1998, An essential role for ectodomain shedding in mammalian development, Science, 282, 1281, 10.1126/science.282.5392.1281

Zhao, 2001, Pulmonary hypoplasia in mice lacking tumor necrosis factor-α converting enzyme indicates an indispensable role for cell surface protein shedding during embryonic lung branching morphogenesis, Dev. Biol., 232, 204, 10.1006/dbio.2001.0176

Sunnarborg, 2002, Tumor necrosis factor-α converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability, J. Biol. Chem., 277, 12838, 10.1074/jbc.M112050200

Sahin, 2004, Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands, J. Cell Biol., 164, 769, 10.1083/jcb.200307137

Hartmann, 2002, The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for α-secretase activity in fibroblasts, Hum. Mol. Genet., 11, 2615, 10.1093/hmg/11.21.2615

Six, 2003, The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase, Proc. Natl. Acad. Sci. U.S.A., 100, 7638, 10.1073/pnas.1230693100

Fridman, 2007, Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer, Clin. Cancer Res., 13, 1892, 10.1158/1078-0432.CCR-06-2116

Moss, 2008, Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis, Nat. Clin. Pract. Rheumatol., 4, 300, 10.1038/ncprheum0797

Le Gall, 2009, ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as TGFα, L-selectin and TNFα, Mol. Biol. Cell, 20, 1785, 10.1091/mbc.e08-11-1135

Horiuchi, 2007, Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx, Mol. Biol. Cell, 18, 176, 10.1091/mbc.e06-01-0014

Thiel, 2006, ErbB-4 and TNF-α converting enzyme localization to membrane microdomains, Biochem. Biophys. Res. Commun., 350, 629, 10.1016/j.bbrc.2006.09.095

Zimina, 2005, Shedding of collagen XVII ectodomain depends on plasma membrane microenvironment, J. Biol. Chem., 280, 34019, 10.1074/jbc.M503751200

Tellier, 2006, The shedding activity of ADAM17 is sequestered in lipid rafts, Exp. Cell Res., 312, 3969, 10.1016/j.yexcr.2006.08.027

Janes, 2005, Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans, Cell, 123, 291, 10.1016/j.cell.2005.08.014

Perez, 1990, A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact, Cell, 63, 251, 10.1016/0092-8674(90)90158-B

Brakebusch, 1994, Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor, J. Biol. Chem., 269, 32488, 10.1016/S0021-9258(18)31661-2

Mullberg, 1994, The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site, J. Immunol., 152, 4958, 10.4049/jimmunol.152.10.4958

Migaki, 1995, Mutational analysis of the membraneproximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site, J. Exp. Med., 182, 549, 10.1084/jem.182.2.549

Chen, 1995, Structural requirements regulate endoproteolytic release of the L-selectin (CD62L) adhesion receptor from the cell surface of leukocytes, J. Exp. Med., 182, 519, 10.1084/jem.182.2.519

Tang, 1996, Length of the linking domain of human pro-tumor necrosis factor determines the cleavage processing, Biochemistry, 35, 8226, 10.1021/bi952183l

Arribas, 1997, Role of the juxtamembrane domains of the transforming growth factor-α precursor and the β-amyloid precursor protein in regulated ectodomain shedding, J. Biol. Chem., 272, 17160, 10.1074/jbc.272.27.17160

Althoff, 2000, Shedding of interleukin-6 receptor and tumor necrosis factor α. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins, Eur. J. Biochem., 267, 2624, 10.1046/j.1432-1327.2000.01278.x

Althoff, 2001, Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins, Biochem. J., 353, 663, 10.1042/bj3530663

Hinkle, 2004, Selective roles for tumor necrosis factor α-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency, J. Biol. Chem., 279, 24179, 10.1074/jbc.M312141200

Black, 2003, Substrate specificity and inducibility of TACE (tumour necrosis factor α-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity, Biochem. Soc. Symp., 70, 39, 10.1042/bss0700039

Mohan, 2002, The tumor necrosis factor-α converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity, Biochemistry, 41, 9462, 10.1021/bi0260132

Jin, 2002, A continuous fluorimetric assay for tumor necrosis factor-αconverting enzyme, Anal. Biochem., 302, 269, 10.1006/abio.2001.5549

Lambert, 2005, Substrate specificity and novel selective inhibitors of TNF-α converting enzyme (TACE) from two-dimensional substrate mapping, Comb. Chem. High Throughput Screen., 8, 327, 10.2174/1386207054020840

Turk, 2001, Determination of protease cleavage site motifs using mixture-based oriented peptide libraries, Nat. Biotechnol., 19, 661, 10.1038/90273

Knight, 1995, Fluorimetric assays of proteolytic enzymes, Methods Enzymol., 248, 18, 10.1016/0076-6879(95)48004-8

Zheng, 2004, Evaluation of the contribution of different ADAMs to tumor necrosis factor α (TNFα) shedding and of the function of the TNFα ectodomain in ensuring selective stimulated shedding by the TNFα convertase (TACE/ADAM17), J. Biol. Chem., 279, 42898, 10.1074/jbc.M403193200

Zheng, 2002, Evidence for regulation of the tumor necrosis factor α-convertase (TACE) by protein-tyrosine phosphatase PTPH1, J. Biol. Chem., 277, 42463, 10.1074/jbc.M207459200

Nagase, 1996, Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides, Biopolymers, 40, 399, 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R

Moss, 2007, Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening, Anal. Biochem., 366, 144, 10.1016/j.ab.2007.04.043

Maskos, 1998, Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzyme, Proc. Natl. Acad. Sci. U.S.A., 95, 3408, 10.1073/pnas.95.7.3408

Ingram, 2006, Stabilization of the autoproteolysis of TNF-α converting enzyme (TACE) results in a novel crystal form suitable for structure-based drug design studies, Protein Eng. Des. Sel., 19, 155, 10.1093/protein/gzj014

Bode, 1999, Structural properties of matrix metalloproteinases, Cell Mol. Life Sci., 55, 639, 10.1007/s000180050320

Welch, 1996, Understanding the P1′ specificity of the matrix metalloproteinases: effect of S1′ pocket mutations in matrilysin and stromelysin-1, Biochemistry, 35, 10103, 10.1021/bi9601969

Reddy, 2000, Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme, J. Biol. Chem., 275, 14608, 10.1074/jbc.275.19.14608

Kahn, 1994, Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin, J. Cell Biol., 125, 461, 10.1083/jcb.125.2.461

Shih, 1990, Serum transferrin receptor is a truncated form of tissue receptor, J. Biol. Chem., 265, 19077, 10.1016/S0021-9258(17)30627-0

Hirako, 2003, The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini, J. Invest. Dermatol., 121, 1554, 10.1046/j.1523-1747.2003.12607.x

Wang, 2002, Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site, J. Biol. Chem., 277, 50510, 10.1074/jbc.M208738200

Dolnik, 2004, Ectodomain shedding of the glycoprotein GP of Ebola virus, EMBO J., 23, 2175, 10.1038/sj.emboj.7600219

Chow, 2008, Metalloproteinase- and γ-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z, J. Biol. Chem., 283, 30879, 10.1074/jbc.M802976200

Mumm, 2000, A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1, Mol. Cell, 5, 197, 10.1016/S1097-2765(00)80416-5

Brou, 2000, A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE, Mol. Cell, 5, 207, 10.1016/S1097-2765(00)80417-7

Esch, 1990, Cleavage of amyloid beta peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583

Chen, 1995, Truncated forms of the human prion protein in normal brain and in prion diseases, J. Biol. Chem., 270, 19173, 10.1074/jbc.270.32.19173

Kummer, 2009, Formation of Pmel17 amyloid is regulated by juxtamembrane metalloproteinase cleavage, and the resulting C-terminal fragment is a substrate for γ-secretase, J. Biol. Chem., 284, 2296, 10.1074/jbc.M808904200

Maretzky, 2005, ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation, Proc. Natl. Acad. Sci. U.S.A., 102, 9182, 10.1073/pnas.0500918102

Uemura, 2006, Characterization of sequential N-cadherin cleavage by ADAM10 and PS1, Neurosci. Lett., 402, 278, 10.1016/j.neulet.2006.04.018

Lemieux, 2007, The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10, J. Biol. Chem., 282, 14836, 10.1074/jbc.M608414200

Schulte, 2007, ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death, Cell Death Differ., 14, 1040, 10.1038/sj.cdd.4402101

Thông tin
Thông tin xuất bản

Biochemical Journal

Tập 424 Số 1

79-88

Thông tin tác giả